Drug Information

Drug General Information
Drug ID
D0XL6P
Former ID
DNC005975
Drug Name
2-morpholino-6-(naphthalen-1-yl)-4H-chromen-4-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527888]
Formula
C23H19NO3
Canonical SMILES
C1COCCN1C2=CC(=O)C3=C(O2)C=CC(=C3)C4=CC=CC5=CC=CC=C54
InChI
1S/C23H19NO3/c25-21-15-23(24-10-12-26-13-11-24)27-22-9-8-17(14-20(21)22)19-7-3-5-16-4-1-2-6-18(16)19/h1-9,14-15H,10-13H2
InChIKey
ALYIMYTWUBXFRH-UHFFFAOYSA-N
PubChem Compound ID
11646132
Target and Pathway
Target(s) DNA-dependent protein kinase catalytic subunit Target Info Inhibitor [527888]
KEGG Pathway Non-homologous end-joining
Cell cycle
NetPath Pathway IL1 Signaling Pathway
Pathway Interaction Database DNA-PK pathway in nonhomologous end joining
Coregulation of Androgen receptor activity
Class I PI3K signaling events mediated by Akt
BARD1 signaling events
Reactome Nonhomologous End-Joining (NHEJ)
WikiPathways DNA Damage Response
Non-homologous end joining
FAS pathway and Stress induction of HSP regulation
Cytosolic sensors of pathogen-associated DNA
Retinoblastoma (RB) in Cancer
Prostate Cancer
Double-Strand Break Repair
Cell Cycle
miRNA Regulation of DNA Damage Response
References
Ref 527888J Med Chem. 2005 Dec 1;48(24):7829-46.Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach.
Ref 527888J Med Chem. 2005 Dec 1;48(24):7829-46.Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.